Transdermal Patch Communication for Timely Medication Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing medication management systems fail to effectively ensure correct use and timely administration of medicines, particularly for transdermal patches, due to lack of real-time monitoring and feedback mechanisms.
Innovation Solution
A medication use support system comprising a communication device integrated with a transdermal patch, a terminal, and a management server, which uses QR codes and wireless communication to monitor and manage patch usage, providing real-time status updates and alerts for correct administration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If a communication device is integrated with a transdermal patch to enable real-time monitoring, then medication use accuracy and timeliness are improved, but device complexity increases
Solution Approach 1:
The communication device is integrated directly into the transdermal patch, merging the medication delivery function with the monitoring and communication function into a single unified device. This eliminates the need for separate monitoring equipment and reduces overall system complexity while improving medication use accuracy through real-time data collection.
Solution Approach 2:
The transdermal patch is designed to perform multiple functions simultaneously: delivering medication through the skin, monitoring usage status, storing patient information, and communicating with external devices. This multi-functionality reduces the need for separate devices and improves reliability by ensuring all functions are coordinated within a single integrated system.
2Loss of time
If real-time monitoring and feedback mechanisms are implemented, then medication administration timeliness is improved, but loss of information increases due to potential communication failures
Solution Approach 1:
The transdermal patch stores patient information, medication details, and communication protocols in its memory unit before actual use. This preliminary preparation ensures that even if communication fails temporarily, the device can continue to deliver medication according to pre-programmed instructions and can resume communication when connectivity is restored without losing critical information.
Solution Approach 2:
The system implements bidirectional communication between the transdermal patch and external devices, providing real-time feedback on medication delivery status, patient response, and usage compliance. This feedback mechanism allows for immediate adjustments and reduces information loss by continuously verifying and updating the system state.
3Reliability
If an electromagnetic wave shielding member is used to control communication states, then reliability of communication control is improved, but ease of operation decreases
Solution Approach 1:
The electromagnetic wave shielding member is designed to automatically transition between shielding and non-shielding states based on the operational requirements of the transdermal patch. The system self-regulates communication states without requiring manual intervention from the user, maintaining reliable communication control while preserving ease of operation through automated behavior.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Ensures accurate and timely use of transdermal patches by patients through real-time monitoring and alerts, reducing errors and improving adherence to prescribed treatment schedules.
Implementation Method 1
the communication device is in an uncommunicable state with the terminal when shielded by an electromagnetic wave shielding member that shields an electromagnetic wave
Implementation Method 2
a reading unit which reads first trigger information for acquiring information of the medicine
Data Source
AI summary
A medication use support system including a communication device provided to a medicine and a terminal that stores and manages medication information, wherein the terminal includes: a reading unit which reads first trigger information for acquiring information of the medicine; a communication unit which performs wireless communication with the communication device; a storage unit which stores management information of the medicine; a display unit which displays a medication use management screen including the management information of the medicine; and a control unit which determines a use status of the medicine by communication with the communication device, the communication device is in a communicable state with the terminal when not shielded by the electromagnetic wave shielding member and transmits second trigger information to the communication unit in the communicable state.